Investigating monoclonal antibody against cytokeratin 19 tumor marker

Mohammad Amin Momeni-Moghaddam, Javad Mohammadnejad, Hossein Ghahremani, Shahnaz Khaghani, Nariman Moradi, Amin Daemi, Gülüzar Özbolat, Yusuf Döğüş, Seyyedeh Touran Hosseini · 2025

Read Investigating monoclonal antibody against cytokeratin 19 tumor marker by Mohammad Amin Momeni-Moghaddam, Javad Mohammadnejad, Hossein Ghahremani, Shahnaz Khaghani, Nariman Moradi, Amin Daemi, Gülüzar Özbolat, Yusuf Döğüş, Seyyedeh Touran Hosseini (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12860061.txt.

Description

Cytokeratin 19, a scaffold protein, appears in many cancers, so a precise antibody against it could aid diagnosis. Mohammad Momeni-Moghaddam and co-authors set out in 2025 to make such a monoclonal antibody. They injected mice with a lab-made copy of the protein, fused the best responders' spleen cells with tumor cells, and screened the hybrid cells for antibody output.

From seventy-eight reactive clones, two stable lines survived repeated single-cell cloning. Tests on cancer cell lines showed the expected bands where the protein occurs, and none in a skin cancer line known to lack it. The pair gives labs a fresh, specific tool for spotting this tumor marker.

Catalog record

CREATORMohammad Amin Momeni-Moghaddam, Javad Mohammadnejad, Hossein Ghahremani, Shahnaz Khaghani, Nariman Moradi, Amin Daemi, Gülüzar Özbolat, Yusuf Döğüş, Seyyedeh Touran Hosseini
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12860061

Browse the full library · About the Tower of Babel